NCT06760624View on ClinicalTrials.gov

Effectiveness of Ofatumumab in Real-world Practice

CompletedOBSERVATIONAL
Enrollment

779

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

January 15, 2024

Study Completion Date

January 15, 2024

Conditions
Multiple Sclerosis
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY